Cline Christopher R.: insider trades.
Cline Christopher R. reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($3.2M), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 5
- Companies
- 1
- Name as filed
- Cline Christopher R.
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | Officer · CHIEF FINANCIAL OFFICER | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Travere Therapeutics, Inc. | S | 27,473 | $62 | 110,543 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | M | 20,000 | $17.44 | 138,016 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 400 | $65.31 | 87,508 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 20,735 | $62.61 | 89,808 | Form 4 |
| 2026-09-15 | Travere Therapeutics, Inc. | S | 1,900 | $63.69 | 87,908 | Form 4 |
| 2026-09-02 | Travere Therapeutics, Inc. | S | 642 | $66.37 | 118,016 | Form 4 |
Questions
What stock did Cline Christopher R. buy or sell?
Cline Christopher R. reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($3.2M), across 1 company.
Is Cline Christopher R. the same person as other filers with this name?
This page covers SEC CIK 1943192 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/cline-christopher-r-1943192.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.